Rein Therapeutics (RNTX) Q3 2026 Earnings

12AugConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.49
-0.39
-0.29
-0.19

Details

Expected EPS
-0.49
Actual EPS
N/A
Surprise EPS
0.49
Surprise Percent
+100%

Description

Rein Therapeutics (RNTX) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts